These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 26441906)
1. Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice. Sonzogni-Desautels K; Renteria AE; Camargo FV; Di Lenardo TZ; Mikhail A; Arrowood MJ; Fortin A; Ndao M Front Microbiol; 2015; 6():973. PubMed ID: 26441906 [TBL] [Abstract][Full Text] [Related]
2. [Highly Active AntiRetroviral Therapy and cryptosporidiosis]. Morales Gomez MA Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695 [TBL] [Abstract][Full Text] [Related]
3. Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasis. Fortin A; Caridha DP; Leed S; Ngundam F; Sena J; Bosschaerts T; Parriott S; Hickman MR; Hudson TH; Grogl M PLoS Negl Trop Dis; 2014 Sep; 8(9):e3144. PubMed ID: 25210745 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis. Fortin A; Hendrickx S; Yardley V; Cos P; Jansen H; Maes L J Antimicrob Chemother; 2012 Nov; 67(11):2707-12. PubMed ID: 22782488 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice. Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052 [TBL] [Abstract][Full Text] [Related]
6. Mouse Models for Use in Cryptosporidium Infection Studies and Quantification of Parasite Burden Using Flow Cytometry, qPCR, and Histopathology. Sonzogni-Desautels K; Mead JR; Ndao M Methods Mol Biol; 2020; 2052():229-251. PubMed ID: 31452166 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis. Van Bocxlaer K; Dixon J; Platteeuw JJ; Van Den Heuvel D; Mcarthur KN; Harris A; Alavijeh M; Croft SL; Yardley V J Antimicrob Chemother; 2023 Jul; 78(7):1723-1731. PubMed ID: 37229566 [TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model. Asadpour M; Namazi F; Razavi SM; Nazifi S Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627 [TBL] [Abstract][Full Text] [Related]
9. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice. Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481 [TBL] [Abstract][Full Text] [Related]
11. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection. Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869 [TBL] [Abstract][Full Text] [Related]
12. Mass Spectrometry Imaging of In Vitro Anschütz NH; Gerbig S; Ghezellou P; Silva LMR; Vélez JD; Hermosilla CR; Taubert A; Spengler B Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627264 [No Abstract] [Full Text] [Related]
13. Quantitative evaluation of infectivity change of Cryptosporidium parvum after gamma irradiation. Lee SU; Joung M; Nam T; Park WY; Yu JR Korean J Parasitol; 2009 Mar; 47(1):7-11. PubMed ID: 19290085 [TBL] [Abstract][Full Text] [Related]
14. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection. Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092 [TBL] [Abstract][Full Text] [Related]
15. Antifungal Activity of Oleylphosphocholine on Holtappels M; Swinnen E; De Groef L; Wuyts J; Moons L; Lagrou K; Van Dijck P; Kucharíková S Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061737 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum. Healey MC; Yang S; Rasmussen KR; Jackson MK; Du C J Parasitol; 1995 Feb; 81(1):114-6. PubMed ID: 7876965 [TBL] [Abstract][Full Text] [Related]
17. Infectivity of Cryptosporidium parvum isolated from asymptomatic adult goats to mice and goat kids. Noordeen F; Horadagoda NU; Faizal AC; Rajapakse RP; Razak MA; Arulkanthan A Vet Parasitol; 2002 Jan; 103(3):217-25. PubMed ID: 11750115 [TBL] [Abstract][Full Text] [Related]
18. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia. Abdou AG; Harba NM; Afifi AF; Elnaidany NF Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034 [TBL] [Abstract][Full Text] [Related]